Annual CAPEX
$2400.00
-$12.70 K-84.11%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual capital expenditures is $2400.00, with the most recent change of -$12.70 thousand (-84.11%) on December 31, 2023.
- During the last 3 years, CYTH annual CAPEX has fallen by -$50.70 thousand (-95.48%).
- CYTH annual CAPEX is now -99.57% below its all-time high of $553.80 thousand, reached on December 31, 2011.
Performance
CYTH CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- CYTH quarterly capital expenditures is not available.
Performance
CYTH Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- CYTH TTM capital expenditures is not available.
Performance
CYTH TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CYTH CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -84.1% | - | - |
3 y3 years | -95.5% | - | - |
5 y5 years | -20.0% | - | - |
CYTH CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -89.3% | at low | ||||
5 y | 5-year | -95.5% | +84.6% | ||||
alltime | all time | -99.6% | +84.6% |
Cyclo Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $2400.00(-84.1%) | - | - |
Dec 2022 | $15.10 K(-32.9%) | $0.00(-100.0%) | $15.10 K(0.0%) |
Sep 2022 | - | $10.50 K(>+9900.0%) | $15.10 K(+228.3%) |
Jun 2022 | - | $0.00(-100.0%) | $4600.00(-83.0%) |
Mar 2022 | - | $4600.00(>+9900.0%) | $27.10 K(+20.4%) |
Dec 2021 | $22.50 K(-57.6%) | $0.00(0.0%) | $22.50 K(0.0%) |
Sep 2021 | - | $0.00(-100.0%) | $22.50 K(0.0%) |
Jun 2021 | - | $22.50 K(>+9900.0%) | $22.50 K(-57.6%) |
Dec 2020 | $53.10 K(+3984.6%) | $0.00(0.0%) | $53.10 K(0.0%) |
Sep 2020 | - | $0.00(-100.0%) | $53.10 K(0.0%) |
Jun 2020 | - | $2500.00(-95.1%) | $53.10 K(+4.9%) |
Mar 2020 | - | $50.60 K(>+9900.0%) | $50.60 K(+3792.3%) |
Dec 2019 | $1300.00(-56.7%) | $0.00(0.0%) | $1300.00(-50.0%) |
Sep 2019 | - | $0.00(0.0%) | $2600.00(0.0%) |
Jun 2019 | - | $0.00(-100.0%) | $2600.00(0.0%) |
Mar 2019 | - | $1300.00(0.0%) | $2600.00(-10.3%) |
Dec 2018 | $3000.00(-56.5%) | $1300.00(>+9900.0%) | $2900.00(+190.0%) |
Sep 2018 | - | $0.00(0.0%) | $1000.00(-76.2%) |
Jun 2018 | - | $0.00(-100.0%) | $4200.00(-39.1%) |
Mar 2018 | - | $1600.00(-366.7%) | $6900.00(0.0%) |
Dec 2017 | $6900.00(-25.8%) | -$600.00(-118.8%) | $6900.00(-8.0%) |
Sep 2017 | - | $3200.00(+18.5%) | $7500.00(+74.4%) |
Jun 2017 | - | $2700.00(+68.8%) | $4300.00(+168.8%) |
Mar 2017 | - | $1600.00(>+9900.0%) | $1600.00(-82.8%) |
Dec 2016 | $9300.00(-97.8%) | $0.00(0.0%) | $9300.00(-89.7%) |
Sep 2016 | - | $0.00(0.0%) | $90.70 K(-55.4%) |
Jun 2016 | - | $0.00(-100.0%) | $203.40 K(-24.3%) |
Mar 2016 | - | $9300.00(-88.6%) | $268.70 K(-35.9%) |
Dec 2015 | $419.20 K(+141.1%) | $81.40 K(-27.8%) | $419.20 K(+11.4%) |
Sep 2015 | - | $112.70 K(+72.6%) | $376.20 K(+26.7%) |
Jun 2015 | - | $65.30 K(-59.1%) | $296.90 K(+7.8%) |
Mar 2015 | - | $159.80 K(+316.1%) | $275.40 K(+58.4%) |
Dec 2014 | $173.90 K(+10.8%) | $38.40 K(+15.0%) | $173.90 K(-23.4%) |
Sep 2014 | - | $33.40 K(-23.7%) | $227.10 K(-11.9%) |
Jun 2014 | - | $43.80 K(-24.9%) | $257.90 K(+20.3%) |
Mar 2014 | - | $58.30 K(-36.4%) | $214.40 K(+36.6%) |
Dec 2013 | $156.90 K(-5.6%) | $91.60 K(+42.7%) | $156.90 K(+11.0%) |
Sep 2013 | - | $64.20 K(>+9900.0%) | $141.30 K(+21.1%) |
Jun 2013 | - | $300.00(-62.5%) | $116.70 K(-2.6%) |
Mar 2013 | - | $800.00(-98.9%) | $119.80 K(-27.9%) |
Dec 2012 | $166.20 K(-70.0%) | $76.00 K(+91.9%) | $166.20 K(+83.8%) |
Sep 2012 | - | $39.60 K(+1064.7%) | $90.40 K(-67.8%) |
Jun 2012 | - | $3400.00(-92.8%) | $280.70 K(-46.4%) |
Mar 2012 | - | $47.20 K(>+9900.0%) | $523.90 K(-5.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $553.80 K(+25.1%) | $200.00(-99.9%) | $553.80 K(-11.6%) |
Sep 2011 | - | $229.90 K(-6.8%) | $626.30 K(+34.7%) |
Jun 2011 | - | $246.60 K(+219.8%) | $464.90 K(+7.2%) |
Mar 2011 | - | $77.10 K(+6.1%) | $433.70 K(-2.0%) |
Dec 2010 | $442.70 K(+920.0%) | $72.70 K(+6.1%) | $442.70 K(+17.6%) |
Sep 2010 | - | $68.50 K(-68.2%) | $376.60 K(+21.1%) |
Jun 2010 | - | $215.40 K(+150.2%) | $310.90 K(+189.7%) |
Mar 2010 | - | $86.10 K(+1204.5%) | $107.30 K(+147.2%) |
Dec 2009 | $43.40 K(-48.6%) | $6600.00(+135.7%) | $43.40 K(-3.8%) |
Sep 2009 | - | $2800.00(-76.3%) | $45.10 K(-17.6%) |
Jun 2009 | - | $11.80 K(-46.8%) | $54.70 K(-15.5%) |
Mar 2009 | - | $22.20 K(+167.5%) | $64.70 K(-23.3%) |
Dec 2008 | $84.40 K(+0.1%) | $8300.00(-33.1%) | $84.40 K(-33.6%) |
Sep 2008 | - | $12.40 K(-43.1%) | $127.20 K(-4.0%) |
Jun 2008 | - | $21.80 K(-48.0%) | $132.50 K(+11.2%) |
Mar 2008 | - | $41.90 K(-18.0%) | $119.20 K(+41.4%) |
Dec 2007 | $84.30 K(+205.4%) | $51.10 K(+188.7%) | $84.30 K(+97.0%) |
Sep 2007 | - | $17.70 K(+108.2%) | $42.80 K(+35.4%) |
Jun 2007 | - | $8500.00(+21.4%) | $31.60 K(-2.2%) |
Mar 2007 | - | $7000.00(-27.1%) | $32.30 K(+17.0%) |
Dec 2006 | $27.60 K(+22.1%) | $9600.00(+47.7%) | $27.60 K(+40.8%) |
Sep 2006 | - | $6500.00(-29.3%) | $19.60 K(+67.5%) |
Jun 2006 | - | $9200.00(+300.0%) | $11.70 K(+21.9%) |
Mar 2006 | - | $2300.00(+43.8%) | $9600.00(-57.5%) |
Dec 2005 | $22.60 K(-72.1%) | $1600.00(-214.3%) | $22.60 K(-53.2%) |
Sep 2005 | - | -$1400.00(-119.7%) | $48.30 K(-30.5%) |
Jun 2005 | - | $7100.00(-53.6%) | $69.50 K(-4.7%) |
Mar 2005 | - | $15.30 K(-44.0%) | $72.90 K(-9.8%) |
Dec 2004 | $80.90 K(+47.9%) | $27.30 K(+37.9%) | $80.80 K(+51.6%) |
Sep 2004 | - | $19.80 K(+88.6%) | $53.30 K(-22.6%) |
Jun 2004 | - | $10.50 K(-54.7%) | $68.90 K(-1.1%) |
Mar 2004 | - | $23.20 K(<-9900.0%) | $69.70 K(+27.4%) |
Dec 2003 | $54.70 K(+205.6%) | -$200.00(-100.6%) | $54.70 K(-0.4%) |
Sep 2003 | - | $35.40 K(+213.3%) | $54.90 K(+181.5%) |
Jun 2003 | - | $11.30 K(+37.8%) | $19.50 K(-16.3%) |
Mar 2003 | - | $8200.00(>+9900.0%) | $23.30 K(+30.2%) |
Dec 2002 | $17.90 K(+92.5%) | $0.00(0.0%) | $17.90 K(-24.2%) |
Sep 2002 | - | $0.00(-100.0%) | $23.60 K(-4.5%) |
Jun 2002 | - | $15.10 K(+439.3%) | $24.70 K(+104.1%) |
Mar 2002 | - | $2800.00(-50.9%) | $12.10 K(+30.1%) |
Dec 2001 | $9300.00(-90.4%) | $5700.00(+418.2%) | $9300.00(+158.3%) |
Sep 2001 | - | $1100.00(-56.0%) | $3600.00(+44.0%) |
Jun 2001 | - | $2500.00 | $2500.00 |
Dec 2000 | $97.00 K | - | - |
FAQ
- What is Cyclo Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Cyclo Therapeutics?
- What is the all time high TTM CAPEX for Cyclo Therapeutics?
What is Cyclo Therapeutics annual capital expenditures?
The current annual CAPEX of CYTH is $2400.00
What is the all time high annual CAPEX for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual capital expenditures is $553.80 K
What is Cyclo Therapeutics annual CAPEX year-on-year change?
Over the past year, CYTH annual capital expenditures has changed by -$12.70 K (-84.11%)
What is the all time high quarterly CAPEX for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly capital expenditures is $246.60 K
What is the all time high TTM CAPEX for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM capital expenditures is $626.30 K